← Every applicant
Sun Pharm Inds Inc FDA Approvals
13 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| SUGAMMADEX SODIUMNew drugJul 28, 2026SOLUTION, INTRAVENOUS |
| TOFACITINIB CITRATENew drugJun 3, 2026SOLUTION, ORAL |
| DEFLAZACORTNew drugJan 27, 2026SUSPENSION, ORAL |
| LEQSELVINew drugJul 25, 2024TABLET, ORAL |
| INDIUM IN-111 PENTETREOTIDE KITNew drugJul 1, 2024INJECTABLE, INJECTION |
| DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATENew drugSep 27, 2023CAPSULE, EXTENDED RELEASE, ORAL |
| LISDEXAMFETAMINE DIMESYLATENew drugAug 25, 2023TABLET, CHEWABLE, ORAL |
| METHYLPHENIDATE HYDROCHLORIDENew drugAug 25, 2023TABLET, EXTENDED RELEASE, ORAL |
| LISDEXAMFETAMINE DIMESYLATENew drugAug 25, 2023CAPSULE, ORAL |
| SEZABYNew drugNov 17, 2022POWDER, INTRAVENOUS |
| DEXMETHYLPHENIDATE HYDROCHLORIDENew drugNov 5, 2021CAPSULE, EXTENDED RELEASE, ORAL |
| LEVORPHANOL TARTRATENew drugJun 17, 2021TABLET, ORAL |
| AMPHETAMINE SULFATENew drugJan 27, 2021TABLET, ORAL |